RudaCure Inc. signed a U.S. clinical trial contract for Sun Bio's medical device MucoPEG on December 21st, and will begin conducting U.S. clinical trials starting in 2021.
http://www.sunbio.com/bbs/board.php?bo_table=news&wr_id=105
1. Title of Clinical Trial
- A post-approval clinical trial to evaluate the efficacy of MucoPEG in comparison with Biotene in patients with dry mouth syndrome
2. Phase of Clinical Trial
- Post-approval clinical trial
3. Target Disease
- Dry mouth syndrome (Xerostomia)